Priftin is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Sanofi-aventis U.s. Llc. The primary component is Rifapentine.
Product ID | 0088-2100_303e8c3c-6971-48c8-9ed4-174d282ffe92 |
NDC | 0088-2100 |
Product Type | Human Prescription Drug |
Proprietary Name | Priftin |
Generic Name | Rifapentine |
Dosage Form | Tablet, Film Coated |
Route of Administration | ORAL |
Marketing Start Date | 2009-03-30 |
Marketing Category | NDA / NDA |
Application Number | NDA021024 |
Labeler Name | sanofi-aventis U.S. LLC |
Substance Name | RIFAPENTINE |
Active Ingredient Strength | 150 mg/1 |
Pharm Classes | Rifamycin Antimycobacterial [EPC],Rifamycins [CS] |
NDC Exclude Flag | N |
Listing Certified Through | 2019-12-31 |
Marketing Start Date | 2009-03-30 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA021024 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2009-03-30 |
Marketing End Date | 2020-11-30 |
Marketing Category | NDA |
Application Number | NDA021024 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2009-03-30 |
Marketing End Date | 2018-06-28 |
Marketing Category | NDA |
Application Number | NDA021024 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2009-03-30 |
Marketing End Date | 2020-11-30 |
Ingredient | Strength |
---|---|
RIFAPENTINE | 150 mg/1 |
SPL SET ID: | f768e337-a948-420a-9fbe-9be359c7a170 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
0088-2100 | Priftin | rifapentine |
0088-2102 | Priftin | rifapentine |
50090-5063 | Priftin | rifapentine |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
PRIFTIN 88163593 not registered Live/Pending |
Aventisub LLC 2018-10-22 |
PRIFTIN 74547387 2061792 Live/Registered |
AVENTISUB LLC 1994-06-30 |